Search
for

    Sort by

    Research 241–270 of 1000+

    1. Analysis of metabolic characteristics of epristeride in zebrafish based on LC-Q-TOF MS and its potential applications in doping control RSC Advances · 2026
    2. Testosterone in COVID-19 – Foe, Friend or Fatal Victim? touchREVIEWS in Endocrinology · 2020 · 12 citations
    3. 5α-Reductase Inhibitors and Chemoprevention: The PCPT and Beyond European Urology Supplements · 2006 · 2 citations
    4. 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder Neuropsychopharmacology · 2015 · 110 citations
    5. Synthesis and biological evaluation of esters of 16-formyl-17-methoxy-dehydroepiandrosterone derivatives as inhibitors of 5α-reductase type 2 Journal of Enzyme Inhibition and Medicinal Chemistry · 2015 · 5 citations
    6. Endocrine evaluation of hirsutism International Journal of Women's Dermatology · 2017 · 29 citations
    7. Causes of hair loss and the developments in hair rejuvenation International Journal of Cosmetic Science · 2002 · 69 citations
    8. Relationships between cerebrospinal fluid GABAergic neurosteroid levels and symptom severity in men with PTSD Psychoneuroendocrinology · 2018 · 59 citations
    9. Sexual dimorphism following in vitro ischemia in the response to neurosteroids and mechanisms of injury BMC Neuroscience · 2020 · 6 citations
    10. Frequency of polycystic ovarian syndrome in women with postadolescent acne Journal of the Egyptian Women's Dermatologic Society (Print) · 2014
    11. USE OF SPIRONOLACTONE IN COMBINATION WITH AN ORAL CONTRACEPTIVE IN TREATMENT OF HIRSUTISM 2004
    12. Farmácia Azevedo Carvalho, Cabeceiras de Bastos Open Repository of the University of Porto (University of Porto) · 2023
    13. Androgenic disorders of women: Diagnostic and therapeutic decision making The American Journal of Medicine · 1995 · 17 citations
    14. Hormonal Therapy for Acne Journal of Cutaneous Medicine and Surgery · 1996 · 1 citations
    15. UTILIDADES DE LA ESPIRONOLACTONA COMO FÁRMACO ANTIANDROGÉNICO La Ciencia al Servicio de la Salud y Nutrición · 2024
    16. Definition criteria and diagnostic assessments 2013
    17. Post-finasteride syndrome – does it really exist? The Aging Male · 2019 · 7 citations
    18. Androgens and hair: a biological paradox Cambridge University Press eBooks · 2001 · 11 citations
    19. Avaliação do impacto da redução significativa de peso pela dieta cetogênica de muito baixa caloria nos parâmetros metabólicos, inflamatórios, hormonais e seminais de homens obesos 2023
    20. Steroid Sulfatase Deficiency and Androgen Activation Before and After Puberty The Journal of Clinical Endocrinology & Metabolism · 2016 · 41 citations
    21. AKR1D1 regulates glucocorticoid availability and glucocorticoid receptor activation in human hepatoma cells 2019 · 17 citations
    22. Dutasteride Drugs · 2008 · 45 citations
    23. Managing patterned hair loss – a hair raising task! Cosmoderma · 2021
    24. Ageratum Conyzoides L. Extract Inhibits 5α-Reductase Gene Expression and Prostaglandin D2 Release in Human Hair Dermal Papilla Cells and Improves Symptoms of Hair Loss in Otherwise Healthy Males and Females in an Open Label Pilot Study Journal of cosmetology & trichology · 2021
    25. 5α-Reductase Inhibitors, Chemical and Clinical Models Steroids · 1998 · 17 citations
    26. 5α-Reductase type 1 inhibition of Oryza sativa bran extract prepared by supercritical carbon dioxide fluid Journal of Supercritical Fluids · 2011 · 22 citations
    27. Effect of 5α-Dihydrotestosterone and Testosterone on Apoptosis in Human Dermal Papilla Cells Skin Pharmacology and Physiology · 2006 · 58 citations
    28. Finasteride, A Steroid 5α-Reductase Inhibitor, Does Not Affect the Oxidative Metabolism of Antipyrine The Journal of Clinical Pharmacology · 1993 · 9 citations
    29. Activity of type 1 5α-reductase is greater in the follicular infrainfundibulum compared with the epidermis British Journal of Dermatology · 1997 · 12 citations
    30. FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects The Journal of Steroid Biochemistry and Molecular Biology · 1996 · 17 citations